Czapska, M., Babkiewicz, K., Pabis, S. and Skórzyńska-Dziduszko, K. (2018) “Sotagliflozin, an inhibitor of sodium–glucose cotransporters 1 and 2 (SGLT1/2), as a new therapeutic approach for patients with type 1 diabetes mellitus”, Journal of Education, Health and Sport, 8(12), pp. 335–351. Available at: https://apcz.umk.pl/JEHS/article/view/6378 (Accessed: 25 April 2024).